BioGaia ABBGLAF 100 OCF Margin % is 18.89% as of Mar. 2026, which is 32% below its 10-year median of 27.97. GuruFocus rates BGLAF with a GF Score™ of 100/100 and a GF Value™ of $13.05. The stock has 5 warning signs investors should review. Among 959 Drug Manufacturers companies, BioGaia AB ranks better than 81.23% on this metric.
The historical rank and industry rank for BioGaia AB's OCF Margin % or its related term are showing as below:
BGLAF'
s OCF Margin % Range Over the Past 10 Years
Min: 19.24 Med: 27.97 Max: 36.2
Current: 22.09
During the past 13 years, the highest OCF Margin % of BioGaia AB was 36.20%. The lowest was 19.24%. And the median was 27.97%.
BGLAF's OCF Margin % is ranked better than 81.23% of 959
companies
in the Drug Manufacturers industry
Industry Median: 9.94
vs BGLAF: 22.09
BioGaia AB OCF Margin % Related Terms
BioGaia AB OCF Margin % Historical Data
* Premium members only.
The historical data trend for BioGaia AB's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, BioGaia AB's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BioGaia AB OCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, BioGaia AB's OCF Margin % distribution charts can be found below:
* The bar in red indicates where BioGaia AB's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BioGaia AB (BGLAF) has a OCF Margin % of 18.89% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on BioGaia AB and its competitors. This is 32% below median its historical median of 27.97. Over the past decade, BioGaia AB's OCF Margin % has ranged from 19.24 to 36.20. According to the industry distribution chart, BioGaia AB ranks #180 out of 959 companies in the Drug Manufacturers industry, placing it in the top 18.8%.
Is BioGaia AB's OCF Margin % too high?
BioGaia AB's current OCF Margin % of 18.89% is 32% below median its 10-year median of 27.97. Over the past 10 years, this metric has ranged from a low of 19.24 to a high of 36.20. The Drug Manufacturers industry median OCF Margin % is 9.94. BioGaia AB's value of 18.89% is 90% above this industry median. Based on the distribution chart, BioGaia AB ranks #180 out of 959 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, BioGaia AB has a GF Score™ of 100/100, reflecting its overall financial health beyond just this single metric.
How does BioGaia AB's OCF Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, BioGaia AB ranks #180 out of 959 companies for OCF Margin %. This places BioGaia AB in the top 19% of its industry — outperforming the majority of peers. The industry median OCF Margin % is 9.94. BioGaia AB's value of 18.89% is 90% above this benchmark. Historically, BioGaia AB's own OCF Margin % has ranged from 19.24 to 36.20 over the past decade. While the company's 10-year median is 27.97 vs. the industry median of 9.94, BioGaia AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.94, based on 959 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. BioGaia AB's current OCF Margin % of 18.89% is 90% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on BioGaia AB and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BioGaia AB's current OCF Margin % is 18.89%, which is 32% below median its own 10-year median of 27.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioGaia AB stock overvalued right now?
BioGaia AB (BGLAF) has a current OCF Margin % of 18.89%. The stock's GF Value™ is $13.05, compared to a current price of $12.20 — trading 6.5% below its estimated fair value. The current OCF Margin % is 18.89%, which is 32% below median its 10-year median of 27.97 and 90% above the Drug Manufacturers industry median of 9.94. BioGaia AB's overall GF Score™ is 100/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For BioGaia AB (BGLAF), the current OCF Margin % is 18.89% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is BioGaia AB (BGLAF) Overvalued in 2026?
Based on GuruFocus' analysis, BioGaia AB stock appears to be undervalued.
The current stock price of $12.20 is trading 6.5% below its estimated GF Value™ of $13.05.
Key valuation signals for BGLAF:
OCF Margin %: 18.89% (32% below median its 10-year median of 27.97)
GF Value™: $13.05 vs. price of $12.20 (6.5% below fair value)
Industry Position: 90% above the Drug Manufacturers median (#180 of 959)
No single metric tells the full story. See the BGLAF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
BioGaia AB is a healthcare company engaged in developing, marketing, and selling probiotic products. The company has three operating segments; Paediatrics segment includes drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products such as infant formula, as well as royalty revenue for pediatric products, Adult Health segment includes gut health tablets, oral health lozenges and cultures as an ingredient in a licensee's dairy products, and Other segment include royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc. Geographically, it operates in three regions: EMEA, the Americas, and APAC (Asia-Pacific, Australia, and New Zealand).
100GF Score
Get the complete analysis for BGLAF
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BGLAF has been successfully added to your 
